2023-03-16 16:04:52 ET
- BioLife Solutions press release ( NASDAQ: BLFS ): Q4 GAAP EPS of -$1.15 misses by $0.99 .
- Revenue of $44.26M (+18.7% Y/Y) beats by $0.94M .
- Cell Processing platform revenue was $20.2 million, up $5.3 million, or 36%, over the same period in 2021. Biopreservation growth was 35%.
- Freezers and Thaw Systems platform revenue was $17.4 million, up $806,000, or 5%, over the same period in 2021. COVID-19 related revenue in 2022 was approximately 3% for this platform.
- Storage and Storage Services platform revenue was $6.7 million, up $810,000, or 14%, over the same period in 2021. COVID-19 related revenue in 2022 was approximately 21% for this platform.
-
Expectations for 2023 total revenue include the following platform contributions:
- Cell processing platform: $89.0 million to $93.0 million, an increase of 30% to 35% over 2022.
- Freezers and Thaw Systems platform: $72.5 million to $79.0 million, an increase of 9% to 18% over 2022. Excluding COVID-19-related revenue, year-over-year growth of 13% to 23%.
- Storage and Storage Services platform: $26.5 million to $30.0 million, flat to an increase of 13% over 2022. Excluding COVID-19-related revenue, year-over-year growth of 64% to 86%.
For further details see:
BioLife Solutions GAAP EPS of -$1.15 misses by $0.99, revenue of $44.26M beats by $0.94M